Ahead of the Bell: Regeneron Pharmaceuticals - BusinessWeek

[INCIID News Feed]

Genetic Engineering News
<img alt="" height="1" width="1" />
Ahead of the Bell: Regeneron Pharmaceuticals
BusinessWeek
Regeneron Pharmaceuticals Inc. and partner Sanofi-Aventis&#39; potential cancer drug met key goals in a late-stage study focusing on colon cancer patients. Late Tuesday, the companies said that Zaltrap, in combination with chemotherapy, met the key goal of ...
Regeneron, Sanofi Therapy Extends Lives of Colorectal Cancer PatientsBloomberg
Regeneron Pharmaceuticals (REGN) Surged To A New High On Phase 3 ResultsRTT News
Second Phase III Study Success for Regeneron and Bayer HealthCare Drug Against ...Genetic Engineering News
MarketWatch -Wall Street Journal -TheStreet.com
all 51 news articles &raquo;


More...